{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:20Z","timestamp":1792783160022,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M764303"],"award-info":[{"award-number":["2024M764303"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nantong University Open Access Fund for Large-Scale Instruments and Equipment","award":["KFJN2535"],"award-info":[{"award-number":["KFJN2535"]}],"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["82473840"],"award-info":[{"award-number":["82473840"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11484-8","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:44:00Z","timestamp":1771418640000},"page":"7185-7200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of 5-fluoro-aminopyrimidine derivatives as dual BTK\/FLT3 inhibitors for the treatment of rheumatoid arthritis"],"prefix":"10.1007","volume":"30","author":[{"given":"Fansheng","family":"Ran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liujie","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"11484_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070856","volume":"384","author":"P Brown","year":"2024","unstructured":"Brown P, Pratt AG, Hyrich KL (2024) Therapeutic advances in rheumatoid arthritis. BMJ 384:e070856","journal-title":"BMJ"},{"issue":"6","key":"11484_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMra2103726","volume":"388","author":"EM Gravallese","year":"2023","unstructured":"Gravallese EM, Firestein GS (2023) Rheumatoid arthritis\u2014common origins, divergent mechanisms. N Engl J Med 388(6):529\u20135424","journal-title":"N Engl J Med"},{"key":"11484_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.172939","volume":"875","author":"Z Liu","year":"2020","unstructured":"Liu Z, Guo S, Dong Q (2020) Nobiletin suppresses IL-21\/IL-21 receptor-mediated inflammatory response in MH7A fibroblast-like synoviocytes (FLS): an implication in rheumatoid arthritis. Eur J Pharmacol 875:172939","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"11484_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01331-9","volume":"8","author":"Q Ding","year":"2023","unstructured":"Ding Q, Hu W, Wang R, Yang Q, Zhu M, Li M, Cai J, Rose P, Mao J, Zhu YZ (2023) Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther 8(1):68","journal-title":"Signal Transduct Target Ther"},{"key":"11484_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113610","volume":"381","author":"Y Jin","year":"2025","unstructured":"Jin Y, Xu C, Zhu Y, Gu Z (2025) Extracellular vesicle as a next-generation drug delivery platform for rheumatoid arthritis therapy. J Control Release 381:113610","journal-title":"J Control Release"},{"issue":"4","key":"11484_CR6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/cells9040880","volume":"9","author":"YJ Lin","year":"2020","unstructured":"Lin YJ, Anzaghe M, Sch\u00fclke S (2020) Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells 9(4):880","journal-title":"Cells"},{"key":"11484_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109714","volume":"115","author":"W Sun","year":"2023","unstructured":"Sun W, Ma J, Chen M, Zhang W, Xu C, Nan Y, Wu W, Mao X, Cheng X, Cai H, Zhang J, Xu H, Wang Y (2023) 4-Iodo-6-phenylpyrimidine (4-IPP) suppresses fibroblast-like synoviocyte- mediated inflammation and joint destruction associated with rheumatoid arthritis. Int Immunopharmacol 115:109714","journal-title":"Int Immunopharmacol"},{"issue":"13","key":"11484_CR8","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320(13):1360\u20131372","journal-title":"JAMA"},{"key":"11484_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jconrel.2024.05.021","volume":"370","author":"Y Wu","year":"2024","unstructured":"Wu Y, Wang Z, Ge Y, Zhu Y, Tian T, Wei J, Jin Y, Zhao Y, Jia Q, Wu J, Ge L (2024) Microenvironment responsive hydrogel exerting inhibition of cascade immune activation and elimination of synovial fibroblasts for rheumatoid arthritis therapy. J Control Release 370:747\u2013762","journal-title":"J Control Release"},{"issue":"10","key":"11484_CR10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrrheum.2009.185","volume":"5","author":"S Khan","year":"2009","unstructured":"Khan S, Greenberg JD, Bhardwaj N (2009) Dendritic cells as targets for therapy in rheumatoid arthritis. Nat Rev Rheumatol 5(10):566\u2013571","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"11484_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","volume":"22","author":"CM Weyand","year":"2021","unstructured":"Weyand CM, Goronzy JJ (2021) The immunology of rheumatoid arthritis. Nat Immunol 22(1):10\u201318","journal-title":"Nat Immunol"},{"issue":"4","key":"11484_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s00044-022-02861-7","volume":"31","author":"FS Ran","year":"2022","unstructured":"Ran FS, Liu Y, Zhao GS (2022) Design and synthesis of novel pyrazolopyrimidine-based derivatives as reversible BTK inhibitors with potent antiproliferative activity in mantle cell lymphoma. Med Chem Res 31(4):594\u2013604","journal-title":"Med Chem Res"},{"issue":"10","key":"11484_CR13","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.3390\/jcm11102807","volume":"11","author":"E Robak","year":"2022","unstructured":"Robak E, Robak T (2022) Bruton\u2019s kinase inhibitors for the treatment of immunological diseases: current status and perspectives. J Clin Med 11(10):2807","journal-title":"J Clin Med"},{"issue":"4","key":"11484_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/ar3400","volume":"13","author":"BY Chang","year":"2011","unstructured":"Chang BY, Huang MM, Francesco M, Chen J, Sokolove J, Magadala P, Robinson WH, Buggy JJ (2011) The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells. Arthritis Res Ther 13(4):R1154","journal-title":"Arthritis Res Ther"},{"issue":"28","key":"11484_CR15","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.2174\/0115680266264515230921052521","volume":"23","author":"P Lin","year":"2023","unstructured":"Lin P, Zhang D, Lin J (2023) Clinical research progress of BTK inhibitors in the treatment of autoimmune diseases. Curr Top Med Chem 23(28):2609\u20132620","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"11484_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14582","volume":"104","author":"S Paliwal","year":"2024","unstructured":"Paliwal S, Bawa S, Shalmali N, Tonk RK (2024) Therapeutic potential and recent progression of BTK inhibitors against rheumatoid arthritis. Chem Biol Drug Des 104(1):e14582","journal-title":"Chem Biol Drug Des"},{"key":"11484_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152681","volume":"72","author":"JD Isaacs","year":"2025","unstructured":"Isaacs JD (2025) Bruton\u2019s tyrosine kinase\u2014A new target for immune mediated inflammatory diseases? Semin Arthritis Rheum 72:1526814","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"11484_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1151592","volume":"5","author":"G Natarajan","year":"2016","unstructured":"Natarajan G, Oghumu S, Terrazas C, Varikuti S, Byrd JC, Satoskar AR (2016) A Tec kinase BTK inhibitor ibrutinib promotes maturation and activation of dendritic cells. Oncoimmunology 5(6):e1151592","journal-title":"Oncoimmunology"},{"issue":"9","key":"11484_CR19","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/imcb.12484","volume":"99","author":"KR Wilson","year":"2021","unstructured":"Wilson KR, Villadangos JA, Mintern JD (2021) Dendritic cell Flt3\u2014regulation, roles and repercussions for immunotherapy. Immunol Cell Biol 99(9):962\u2013971","journal-title":"Immunol Cell Biol"},{"issue":"46","key":"11484_CR20","doi-asserted-by":"publisher","first-page":"16741","DOI":"10.1073\/pnas.0506088102","volume":"102","author":"KA Whartenby","year":"2005","unstructured":"Whartenby KA, Calabresi PA, McCadden E, Nguyen B, Kardian D, Wang T, Mosse C, Pardoll DM, Small D (2005) Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease. Proc Natl Acad Sci USA 102(46):16741\u201316746","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"11484_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16213719","volume":"16","author":"S Schlaweck","year":"2024","unstructured":"Schlaweck S, Radcke A, Kampmann S, Becker BV, Brossart P, Heine A (2024) The immunomodulatory effect of different FLT3 inhibitors on dendritic cells. Cancers 16(21):3719","journal-title":"Cancers"},{"issue":"11","key":"11484_CR22","volume":"9","author":"SC Lin","year":"2020","unstructured":"Lin SC, Lin CC, Li S, Lin WY, Lehman CW, Bracci NR, Tsai SW (2020) Alleviation of collagen-induced arthritis by crotonoside through modulation of dendritic cell differentiation and activation. Plants (Basel) 9(11):1535","journal-title":"Plants (Basel)"},{"key":"11484_CR23","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.2147\/IJN.S522245","volume":"20","author":"S Wang","year":"2025","unstructured":"Wang S, Zhang K, Wang L, Guo Y (2025) Stem cell-derived exosomes with high expression of PD-L1 as nanotherapeutics in rheumatoid arthritis model mice. Int J Nanomed 20:8935\u201389494","journal-title":"Int J Nanomed"},{"issue":"8","key":"11484_CR24","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1136\/annrheumdis-2021-221754","volume":"81","author":"S Saevarsdottir","year":"2022","unstructured":"Saevarsdottir S, Stefansdottir L, Sulem P, Thorleifsson G, Ferkingstad E, Rutsdottir G, Glintborg B, Westerlind H, Grondal G, Loft IC, Sorensen SB, Lie BA, Brink M, \u00c4rlestig L, Arnthorsson AO, Baecklund E, Banasik K, Bank S, Bjorkman LI, Ellingsen T, Erikstrup C, Frei O, Gjertsson I, Gudbjartsson DF, Gudjonsson SA, Halldorsson GH, Hendricks O, Hillert J, Hogdall E, Jacobsen S, Jensen DV, Jonsson H, Kastbom A, Kockum I, Kristensen S, Kristjansdottir H, Larsen MH, Linauskas A, Hauge EM, Loft AG, Ludviksson BR, Lund SH, Markusson T, Masson G, Melsted P, Moore KHS, Munk H, Nielsen KR, Norddahl GL, Oddsson A, Olafsdottir TA, Olason PI, Olsson T, Ostrowski SR, H\u00f8rslev-Petersen K, Rognvaldsson S, Sanner H, Silberberg GN, Stefansson H, S\u00f8rensen E, S\u00f8rensen IJ, Turesson C, Bergman T, Alfredsson L, Kvien TK, Brunak S, Steinsson K, Andersen V, Andreassen OA, Rantap\u00e4\u00e4-Dahlqvist S, Hetland ML, Klareskog L, Askling J, Padyukov L, Pedersen OB, Thorsteinsdottir U, Jonsdottir I, Stefansson K (2022) Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset. Ann Rheum Dis 81(8):1085\u20131095","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"11484_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/ar4403","volume":"15","author":"MI Ramos","year":"2013","unstructured":"Ramos MI, Perez SG, Aarrass S, Helder B, Broekstra P, Gerlag DM, Reedquist KA, Tak PP, Lebre MC (2013) FMS-related tyrosine kinase 3 ligand (Flt3L)\/CD135 axis in rheumatoid arthritis. Arthritis Res Ther 15(6):R209","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"11484_CR26","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1002\/art.27638","volume":"62","author":"KD Deane","year":"2010","unstructured":"Deane KD, O\u2019Donnell CI, Hueber W, Majka DS, Lazar AA, Derber LA, Gilliland WR, Edison JD, Norris JM, Robinson WH, Holers VM (2010) The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum 62(11):3161\u20133172","journal-title":"Arthritis Rheum"},{"issue":"4","key":"11484_CR27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1189\/jlb.1110640","volume":"90","author":"M Dehlin","year":"2011","unstructured":"Dehlin M, Andersson S, Erlandsson M, Brisslert M, Bokarewa M (2011) Inhibition of fms-like tyrosine kinase 3 alleviates experimental arthritis by reducing formation of dendritic cells and antigen presentation. J Leukoc Biol 90(4):811\u2013817","journal-title":"J Leukoc Biol"},{"issue":"8","key":"11484_CR28","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.4049\/jimmunol.1200675","volume":"189","author":"B Madan","year":"2012","unstructured":"Madan B, Goh KC, Hart S, William AD, Jayaraman R, Ethirajulu K, Dymock BW, Wood JM (2012) SB1578, a novel inhibitor of JAK2, FLT3, and c-Fms for the treatment of rheumatoid arthritis. J Immunol 189(8):4123\u20134134","journal-title":"J Immunol"},{"key":"11484_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.ejmech.2017.10.021","volume":"143","author":"NM Raghavendra","year":"2018","unstructured":"Raghavendra NM, Pingili D, Kadasi S, Mettu A, Prasad S (2018) Dual or multi-targeting inhibitors: the next generation anticancer agents. Eur J Med Chem 143:1277\u20131300","journal-title":"Eur J Med Chem"},{"issue":"Pt 1","key":"11484_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114913","volume":"245","author":"F Ran","year":"2023","unstructured":"Ran F, Xie X, Wu Q, Wu H, Liu Y, Tao W, Sun Y, Wang R, Zhang Y, Ling Y (2023) Development of novel hydrazidoarylaminopyrimidine-based BTK\/FLT3 dual inhibitors with potent in vivo anti-hematological malignancies effects. Eur J Med Chem 245(Pt 1):114913","journal-title":"Eur J Med Chem"},{"key":"11484_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106479","volume":"134","author":"F Ran","year":"2023","unstructured":"Ran F, Liu Y, Zhu J, Deng X, Wu H, Tao W, Xie X, Hu Y, Zhang Y, Ling Y (2023) Design, synthesis and pharmacological characterization of aminopyrimidine derivatives as BTK\/FLT3 dual-target inhibitors against acute myeloid leukemia. Bioorg Chem 134:106479","journal-title":"Bioorg Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11484-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11484-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11484-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:04:07Z","timestamp":1791165847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11484-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11484"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11484-8","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}